Hypertension, cerebrovascular impairment, and cognitive decline in aged AβPP/PS1 mice

Maximilian Wiesmann1, Valerio Zerbi2, Diane Jansen1

  • 1Radboud university medical center, Donders Institute for Brain, Cognition & Behaviour, Radboud Alzheimer Center, Department of Anatomy, Preclinical Imaging Centre PRIME, Nijmegen, The Netherlands.

Theranostics
|April 25, 2017
PubMed

Insights

High blood pressure in aging mice with Alzheimer's disease (AD) correlates with reduced brain blood flow, impaired brain connectivity, and cognitive decline. This model offers insights into early AD development and potential treatments.

Area of Science:

  • Neuroscience
  • Cardiovascular Research
  • Alzheimer's Disease Pathogenesis

Background:

  • Hypertension is a significant risk factor for Alzheimer's disease (AD).
  • Understanding the vascular contributions to neurodegeneration is crucial for early AD intervention.

Purpose of the Study:

  • To investigate the relationship between systolic blood pressure (SBP), cerebral blood flow (CBF), and brain changes in an aging mouse model of AD.
  • To explore the vascular origins of neurodegenerative processes in Alzheimer's disease.

Main Methods:

  • Utilized a double transgenic AβPPswe/PS1dE9 mouse model for AD.
  • Employed advanced MRI techniques to assess cerebral blood flow, brain connectivity, and structure.
  • Conducted post-mortem analyses for neuroinflammation, synaptogenesis, and neurogenesis.

Main Results:

  • Aging AβPP/PS1 mice exhibited increased SBP, decreased regional CBF, and impaired functional/structural brain connectivity.
  • Cognitive deficits, increased locomotor activity, and anxiety-like behaviors were observed in AD-like mice.
  • Elevated neuroinflammation, reduced synaptogenesis/neurogenesis, and altered brain fatty acid metabolism were noted.

Conclusions:

  • Increased SBP is linked to reduced cerebral hemodynamics and connectivity in an aging AD mouse model, contributing to cognitive and behavioral impairments.
  • The findings mirror early-stage AD symptomatology, suggesting the model's utility for studying prevention and treatment strategies.
  • This research aids in developing better diagnostics and therapies for the prodromal phase of Alzheimer's disease.

Related Concept Videos